Development of bioreactor scale‐down model using orthogonal projections to latent structures method and CO 2 supplementation
Biotechnology Progress · 2024
DOI: 10.1002/btpr.3423 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Progress, 2024. Verfasst von Jinxin Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Statistics, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Bioreactors, Carbon Dioxide. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Scale‐down model qualification is an important step for developing a large‐scale cell culture process to enhance process understanding and support process characterization studies. Traditionally, only harvest data are used to show consistency between small‐scale and large‐scale bioreactor performance, allowing attributes that are dynamic over the cell culture period to be overlooked. A novel statistical method, orthogonal projections to latent structures (OPLS) analysis, can be utilized to compare time‐course cell culture data across scales. Here we describe an example where OPLS is used to identify gaps between small‐scale and large‐scale bioreactor performances. In this case, differences in the partial pressure of carbon dioxide (pCO 2 ) and lactate profiles were observed between small‐ and large‐scale bioreactors, which were linked to differences in the product‐quality attributes fragments and galactosylation. An improved small‐scale model was developed, leading to improved consistency in the process performance and product qualities across scales and qualification of the scale‐down model for regulatory submissions. This new statistical approach can provide valuable insights into process understanding and process scale‐up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Statistics, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA.
- Global Regulatory Affairs, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA.
- Bioproduct Research and Development, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA.
ORCID-Profile: Yao-Ming Huang
Zitieren
APA
Gao, J., Hazeltine, L. B., Stroud, N., Liu, N., & Huang, Y. M. (2024). Development of bioreactor scale‐down model using orthogonal projections to latent structures method and CO 2 supplementation. Biotechnology Progress. https://doi.org/10.1002/btpr.3423
Vancouver
Gao J, Hazeltine LB, Stroud N, Liu N, Huang YM. Development of bioreactor scale‐down model using orthogonal projections to latent structures method and CO 2 supplementation. Biotechnology Progress. 2024. doi:10.1002/btpr.3423
BibTeX
@article{Gao2024,
author = {Gao, Jinxin and Hazeltine, Laurie B and Stroud, Neal and Liu, Ning and Huang, Yao-Ming},
title = {Development of bioreactor scale‐down model using orthogonal projections to latent structures method and CO 2 supplementation},
journal = {Biotechnology Progress},
year = {2024},
doi = {10.1002/btpr.3423}
}
EUVIMED